X4 Pharmaceuticals, Inc Operating Margin in % from Q3 2019 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
X4 Pharmaceuticals, Inc quarterly/annual Operating Margin history and growth rate from Q3 2019 to Q3 2025.
  • X4 Pharmaceuticals, Inc Operating Margin for the quarter ending September 30, 2025 was -291 %.
  • X4 Pharmaceuticals, Inc annual Operating Margin for 2024 was -1.42K %.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)

X4 Pharmaceuticals, Inc Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -291 Jul 1, 2025 Sep 30, 2025
Q2 2025 -323 Apr 1, 2025 Jun 30, 2025
Q1 2025 -27.3 Jan 1, 2025 Mar 31, 2025
Q4 2024 -1.42K Oct 1, 2024 Dec 31, 2024
Q4 2020 -2K Oct 1, 2020 Dec 31, 2020
Q3 2020 -1.77K -373 -26.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 -1.77K Apr 1, 2020 Jun 30, 2020
Q1 2020 -1.73K Jan 1, 2020 Mar 31, 2020
Q3 2019 -1.4K Jul 1, 2019 Sep 30, 2019

X4 Pharmaceuticals, Inc Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -1.42K Jan 1, 2024 Dec 31, 2024
2020 -2K Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.